Vertex Pharmaceuticals (Brazil) Probability of Future Stock Price Finishing Under 512.2

VRTX34 Stock  BRL 619.20  14.62  2.42%   
Vertex Pharmaceuticals' future price is the expected price of Vertex Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vertex Pharmaceuticals Incorporated performance during a given time horizon utilizing its historical volatility. Check out Vertex Pharmaceuticals Backtesting, Vertex Pharmaceuticals Valuation, Vertex Pharmaceuticals Correlation, Vertex Pharmaceuticals Hype Analysis, Vertex Pharmaceuticals Volatility, Vertex Pharmaceuticals History as well as Vertex Pharmaceuticals Performance.
For information on how to trade Vertex Stock refer to our How to Trade Vertex Stock guide.
  
Please specify Vertex Pharmaceuticals' target price for which you would like Vertex Pharmaceuticals odds to be computed.

Vertex Pharmaceuticals Target Price Odds to finish below 512.2

The tendency of Vertex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to R$ 512.20  or more in 90 days
 619.20 90 days 512.20 
near 1
Based on a normal probability distribution, the odds of Vertex Pharmaceuticals to drop to R$ 512.20  or more in 90 days from now is near 1 (This Vertex Pharmaceuticals Incorporated probability density function shows the probability of Vertex Stock to fall within a particular range of prices over 90 days) . Probability of Vertex Pharmaceuticals price to stay between R$ 512.20  and its current price of R$619.2 at the end of the 90-day period is nearly 4.98 .
Assuming the 90 days trading horizon Vertex Pharmaceuticals Incorporated has a beta of -0.51. This entails as returns on the benchmark increase, returns on holding Vertex Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Vertex Pharmaceuticals Incorporated is likely to outperform the market. Additionally Vertex Pharmaceuticals Incorporated has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Vertex Pharmaceuticals Price Density   
       Price  

Predictive Modules for Vertex Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vertex Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
616.69619.20621.71
Details
Intrinsic
Valuation
LowRealHigh
541.69544.20681.12
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceuticals. Your research has to be compared to or analyzed against Vertex Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Vertex Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Vertex Pharmaceuticals.

Vertex Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vertex Pharmaceuticals is not an exception. The market had few large corrections towards the Vertex Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vertex Pharmaceuticals Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vertex Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.04
β
Beta against Dow Jones-0.51
σ
Overall volatility
33.56
Ir
Information ratio -0.04

Vertex Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vertex Stock often depends not only on the future outlook of the current and potential Vertex Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding257 M

Vertex Pharmaceuticals Technical Analysis

Vertex Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Vertex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vertex Pharmaceuticals Incorporated. In general, you should focus on analyzing Vertex Stock price patterns and their correlations with different microeconomic environments and drivers.

Vertex Pharmaceuticals Predictive Forecast Models

Vertex Pharmaceuticals' time-series forecasting models is one of many Vertex Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vertex Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vertex Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vertex Pharmaceuticals' short interest history, or implied volatility extrapolated from Vertex Pharmaceuticals options trading.

Other Information on Investing in Vertex Stock

Vertex Pharmaceuticals financial ratios help investors to determine whether Vertex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vertex with respect to the benefits of owning Vertex Pharmaceuticals security.